Neuroimaging alterations and relapse in early-stage psychosis
Journal of Psychiatry and Neuroscience · 2024
DOI: 10.1503/jpn.230115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Psychiatry and Neuroscience, 2024. Verfasst von Marina Mihaljevic und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Psychiatry (Mihaljevic, Nagpal, Etyemez, Narita, Ross, Schaub, Cascella, Coughlin, Nestadt, Nucifora, Sedlak, Yang, Sawa), Radiology a…. Hauptthemen laut MEDLINE: Schizophrenia, Psychotic Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS.
Abstract (Originalsprache)
Background
Recent reports have indicated that symptom exacerbation after a period of improvement, referred to as relapse, in early-stage psychosis could result in brain changes and poor disease outcomes. We hypothesized that substantial neuroimaging alterations may exist among patients who experience relapse in early-stage psychosis.
Methods
We studied patients with psychosis within 2 years after the first psychotic event and healthy controls. We divided patients into 2 groups, namely those who did not experience relapse between disease onset and the magnetic resonance imaging (MRI) scan (no-relapse group) and those who did experience relapse between these 2 timings (relapse group). We analyzed 3003 functional connectivity estimates between 78 regions of interest (ROIs) derived from resting-state functional MRI data by adjusting for demographic and clinical confounding factors.
Results
We studied 85 patients, incuding 54 in the relapse group and 31 in the no-relapse group, along with 94 healthy controls. We observed significant differences in 47 functional connectivity estimates between the relapse and control groups after multiple comparison corrections, whereas no differences were found between the no-relapse and control groups. Most of these pathological signatures (64%) involved the thalamus. The Jonckheere–Terpstra test indicated that all 47 functional connectivity changes had a significant cross-group progression from controls to patients in the no-relapse group to patients in the relapse group.
Limitations
Longitudinal studies are needed to further validate the involvement and pathological importance of the thalamus in relapse.
Conclusion
We observed pathological differences in neuronal connectivity associated with relapse in early-stage psychosis, which are more specifically associated with the thalamus. Our study implies the importance of considering neurobiological mechanisms associated with relapse in the trajectory of psychotic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Departments of Psychiatry (Mihaljevic, Nagpal, Etyemez, Narita, Ross, Schaub, Cascella, Coughlin, Nestadt, Nucifora, Sedlak, Yang, Sawa), Radiology and Radiological Sciences (Faria), Neuroscience (Sawa), Biomedical Engi…
Förderung
- NIMH NIH HHS
Zitieren
APA
Mihaljevic, M., Nagpal, A., Etyemez, S., Narita, Z., Ross, A., Schaub, R., Cascella, N. G., Coughlin, J. M., Nestadt, G., Nucifora, F. C., Sedlak, T. W., Calhoun, V. D., Faria, A. V., Yang, K., & Sawa, A. (2024). Neuroimaging alterations and relapse in early-stage psychosis. Journal of Psychiatry and Neuroscience. https://doi.org/10.1503/jpn.230115
Vancouver
Mihaljevic M, Nagpal A, Etyemez S, Narita Z, Ross A, Schaub R, et al. Neuroimaging alterations and relapse in early-stage psychosis. Journal of Psychiatry and Neuroscience. 2024. doi:10.1503/jpn.230115
BibTeX
@article{Mihaljevic2024,
author = {Mihaljevic, Marina and Nagpal, Anisha and Etyemez, Semra and Narita, Zui and Ross, Anna and Schaub, Rebecca and Cascella, Nicola G and Coughlin, Jennifer M and Nestadt, Gerald and Nucifora, Frederik C and Sedlak, Thomas W and Calhoun, Vince D and Faria, Andreia V and Yang, Kun and Sawa, Akira},
title = {Neuroimaging alterations and relapse in early-stage psychosis},
journal = {Journal of Psychiatry and Neuroscience},
year = {2024},
doi = {10.1503/jpn.230115}
}
EUVIMED